Person profile
Public information reviewedBenjamin Hohl
Role
Chief Financial Officer and Head of Corporate Development at Enliven Therapeutics, Inc. (NASDAQ: ELVN)
Enliven Therapeutics, Inc. (NASDAQ: ELVN)
Chief Financial Officer and Head of Corporate Development · Current mandate
C Suite · Us Listed
- Public sources
- 1 reviewed
- Profile ownership
- Not yet claimed
- Last reviewed
- Sep 6, 2026
Alpha Registry